Verve Therapeutics Inc (VERV) Stock: A Year of Market Movement, Down and Up

ALXO Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Verve Therapeutics Inc’s current trading price is 18.78% away from its 52-week high, while its distance from the 52-week low is 285.83%. The stock’s price range over this period has fluctuated between $2.86 and $9.31. The company, operating within the financial sector, had a trading volume of approximately 58.47 million for the day, which was noticeably higher than the average daily share volume of 3.47 million over the last 3 months.

Verve Therapeutics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $9.31 on 06/17/25, while the lowest value for the same period was recorded at $2.86 on 04/09/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Verve Therapeutics Inc (VERV) has experienced a quarterly rise of 91.56% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 985.29M and boasts a workforce of 274 employees.

Analyzing Trading Volume and Moving Average Trends

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for VERV stands at 0.14. Similarly, the long-term debt-to-equity ratio is also 0.12.

VERV Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price gain of 95.97% this year. Over the last six months, there has been a weaker performance of 77.41%. The price of VERV fallen by 138.72% during the last 30 days period. For the last 5-days stocks have improved 73.11%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.